PMID- 15890528 OWN - NLM STAT- MEDLINE DCOM- 20050829 LR - 20211109 IS - 1044-7431 (Print) IS - 1044-7431 (Linking) VI - 29 IP - 3 DP - 2005 Jul TI - Activation of microglia by aggregated beta-amyloid or lipopolysaccharide impairs MHC-II expression and renders them cytotoxic whereas IFN-gamma and IL-4 render them protective. PG - 381-93 AB - 'Protective autoimmunity' refers to a well-controlled anti-self response that helps the body resist neurodegeneration. The response is mediated by autoimmune T cells, which produce cytokines and growth factors. Using an in vitro assay of hippocampal slices, we show that the cytokines interferon-gamma and (especially) interleukin-4, characteristic of pro-inflammatory and anti-inflammatory T cells, respectively, can make microglia neuroprotective. Aggregated beta-amyloid, like bacterial cell wall-derived lipopolysaccharide, rendered the microglia cytotoxic. Cytotoxicity was correlated with a signal transduction pathway that down-regulates expression of class-II major histocompatibility proteins (MHC-II) through the MHC-II-transactivator and the invariant chain. Protection by interleukin-4 was attributed to down-regulation of tumor necrosis factor-alpha and up-regulation of insulin-like growth factor I. These findings suggest that beneficial or harmful expression of the local immune response in the damaged CNS depends on how microglia interpret the threat, and that a well-regulated T-cell-mediated response enables microglia to alleviate rather than exacerbate stressful situations in the CNS. FAU - Butovsky, Oleg AU - Butovsky O AD - Department of Neurobiology, The Weizmann Institute of Science, 76100 Rehovot, Israel. FAU - Talpalar, Adolfo E AU - Talpalar AE FAU - Ben-Yaakov, Keren AU - Ben-Yaakov K FAU - Schwartz, Michal AU - Schwartz M LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Mol Cell Neurosci JT - Molecular and cellular neurosciences JID - 9100095 RN - 0 (Amyloid beta-Peptides) RN - 0 (Histocompatibility Antigens Class II) RN - 0 (Lipopolysaccharides) RN - 0 (Tumor Necrosis Factor-alpha) RN - 207137-56-2 (Interleukin-4) RN - 67763-96-6 (Insulin-Like Growth Factor I) RN - 82115-62-6 (Interferon-gamma) SB - IM MH - Amyloid beta-Peptides/antagonists & inhibitors/immunology/pharmacology MH - Animals MH - Animals, Newborn MH - Autoimmunity/drug effects/immunology MH - Cell Line MH - Cells, Cultured MH - Down-Regulation/drug effects/immunology MH - Encephalitis/*immunology/physiopathology/therapy MH - Gliosis/*immunology/physiopathology/therapy MH - Hippocampus/drug effects/immunology/physiopathology MH - Histocompatibility Antigens Class II/drug effects/*immunology MH - Insulin-Like Growth Factor I/drug effects/immunology MH - Interferon-gamma/*immunology/pharmacology MH - Interleukin-4/*immunology/pharmacology MH - Lipopolysaccharides/antagonists & inhibitors/immunology/pharmacology MH - Lymphocyte Activation/drug effects/immunology MH - Microglia/drug effects/*immunology MH - Neurodegenerative Diseases/immunology/physiopathology/therapy MH - Organ Culture Techniques MH - Rats MH - Rats, Sprague-Dawley MH - T-Lymphocytes/drug effects/immunology MH - Transcriptional Activation/drug effects/physiology MH - Tumor Necrosis Factor-alpha/drug effects/immunology EDAT- 2005/05/14 09:00 MHDA- 2005/08/30 09:00 CRDT- 2005/05/14 09:00 PHST- 2004/09/19 00:00 [received] PHST- 2005/03/13 00:00 [revised] PHST- 2005/03/15 00:00 [accepted] PHST- 2005/05/14 09:00 [pubmed] PHST- 2005/08/30 09:00 [medline] PHST- 2005/05/14 09:00 [entrez] AID - S1044-7431(05)00056-4 [pii] AID - 10.1016/j.mcn.2005.03.005 [doi] PST - ppublish SO - Mol Cell Neurosci. 2005 Jul;29(3):381-93. doi: 10.1016/j.mcn.2005.03.005.